Which adverse effects are classified as very common in adults treated with Sirturo (bedaquiline)?

Very common effects (≥1/10) in adults receiving Sirturo (bedaquiline) combination therapy are headache, dizziness, nausea, vomiting, increased transaminases, arthralgia and ECG QT prolongation, with frequencies derived from Phase III treatment; increased transaminases and QT prolongation were common in the controlled Phase IIb study.